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ABSTRACT 
 
BACKGROUND  
Pharmacies are increasingly providing services related to contraception and sexually transmitted 
infections. Identifying pharmacy staff and users’ experiences and attitudes relating to sexual health 
services is critical to understand users’ needs and examining how pharmacy staff can most effectively 
contribute to patient-centred care. This systematic review aimed to examine pharmacy staff and 
pharmacy users’ experiences and attitudes towards the delivery of a large range of sexual health 
services. 
 
METHODS 
Seven electronic databases and the reference lists of all included studies were searched in 
September 2018. Studies giving insight into pharmacy users’ and pharmacy staff’s experiences and 
attitudes towards the delivery of services related to contraception and sexually transmitted infections 
were included. The Mixed Methods Appraisal Tool was used to assess the quality of included studies 
and a narrative synthesis applied to analyse evidence. 
 
RESULTS 
Nineteen studies were included. Eleven studies looked at pharmacy staff, four at users and four at 
both groups. Users found services accessible and convenient and staff found service provision 
feasible. However, several barriers to service delivery were identified including lack of privacy for 
delivering services, lack of trained staff available to provide services, and subjective judgements 
being made on who should be provided or offered a service. 
 
DISCUSSION  
Barriers to service delivery need to be addressed to allow pharmacies to deliver their full potential. 
Future research on pharmacy-based gonorrhoea and syphilis screening, and hepatitis B vaccination 
is needed.  
 
SYSTEMATIC REVIEW REGISTRATION NUMBER: 
CRD42018106807 
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INTRODUCTION 
 
Worldwide, more than a million people acquire a sexually transmitted infection (STI) daily (1) and 
around 44% (99.1 million) of all pregnancies in 2010 to 2014 were unintended (2). Unintended 
pregnancies can cause worse health, economic and social outcomes for women (3,4) and STIs can 
have severe reproductive, sexual and maternal-child health consequences (1). Hence, STIs and 
unintended pregnancies are major concerns (5,6) and the provision of sexual health services 
addressing STIs and unintended pregnancy are highly important.  
 
Pharmacies have the potential to improve access to sexual health services by virtue of their 
numerous locations; and since industrialised countries face new challenges associated with rising 
costs and demand, limited financial resources, and a shortage of human resources (7,8), several 
countries have recently implemented policies to expand pharmacists’ roles (9). For example, 
pharmacists in England are now providing a range of public health services such as smoking 
cessation and services for drug misusers (10,11). Further, they are increasingly providing services 
such as contraception and the screening and treatment of STIs. 
 
As a consequence of pharmacies’ service expansion, the  role of pharmacy staff is changing from 
drug dispenser to patient-centred care provider (7,12). Examining pharmacy staff experiences and 
attitudes to sexual health services is critical to understand whether they deliver a consistent and high 
quality service (12). Further, exploring pharmacy users’ experiences and attitudes may identify 
training needs and improve service delivery (7). 
 
A recent systematic review focused on young people’s experiences and found pharmacy-based 
sexual health services to be appealing to and used by this group, although some pharmacy staff 
created a barrier to service access or refused access (13). Another review has explored the 
acceptability of and barriers to chlamydia testing and included both user and staff perspectives (14). 
This review showed that chlamydia screening is feasible, accessible and convenient and that 
incentives can increase access to testing. Another review on pharmacy-based sexual health services 
looked at emergency contraception and found that women liked the service but had concerns about 
the advice provided on future contraception and STIs (15). Previous reviews have focused particularly 
on emergency contraception and chlamydia screening. 
 
Therefore, our review aimed to systematically summarise and critically appraise pharmacy users’ and 
staff experiences and attitudes towards the delivery of a large range of pharmacy-based sexual health 
services.  
 
METHODS 
 
This review is reported using the PRISMA reporting framework (16). The PRISMA checklist can be 
found attached (see research checklist). The protocol was published in August 2018 on PROSPERO 
(Registration number: CRD42018106807) and is available from: https://bit.ly/2QIegjv.  
 
Inclusion and exclusion criteria 
 
The review included qualitative studies (interviews, focus groups, ethnography), quantitative studies 
(randomised controlled trials [RCTs], cross-sectional studies, cohort studies) and mixed method 
studies. The population of interest was users and providers of pharmacy-based sexual health 
services. Only studies based in countries within the Organisation for Economic Co-operation and 
Development (OECD) were included. This was to ensure that results could inform current practice in 
OECD member countries. A wide range of pharmacy services were included in this review as being 
relevant to the research question.(17) These were: condoms, emergency contraception (EC), 
Chlamydia, gonorrhoea, syphilis and HIV screening, Chlamydia treatment, oral contraceptive pill, 
contraceptive injection, hepatitis B vaccine and partner notification for chlamydia. Studies with and 
without a comparator group were eligible for inclusion. The outcome groupings of interest were broad 
to reflect the wide range of possible relevant outcomes for the review question.  
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The Cochrane Effective Practice and Organisation of Care outcome framework  was used to 
categorise the outcomes of interest (18): Service user outcomes (e.g. experience, barriers and 
enablers), Provider outcomes (e.g. experience; workload; work morale), Social outcomes (e.g. 
empowerment), Attitudes (e.g. service users’, providers’), Satisfaction (e.g. service users’, providers’).  
 
Search Strategy 
 
Cochrane, Embase, Medline, Popline, PsycINFO, Scopus and Web of Science, and the reference 
lists of all included studies were searched without language restrictions on the 17th September 2018. 
Only literature from the past ten years was included (10) to ensure findings would inform current 
practice, which is consistent with previous reviews in the same field. (10) (14).  
 
The search strategy was informed by previous reviews in the field (13–15) and compiled by JG in 
collaboration with HA, JR and a librarian. The search was adapted for each database by mapping the 
keywords “pharmacy/pharmacies” with terms associated with contraception and STIs. The search 
strategy utilised for Medline is presented in Appendix 1.  
 
Selection of studies 
 
All articles initially identified were deduplicated and the remaining titles and abstracts screened 
against the inclusion criteria by two researchers independently. Disagreements were resolved through 
discussion with another researcher. The full texts of potentially relevant articles were retrieved and 
dual screened against pre-defined criteria. If an article was excluded at this stage, the reason was 
recorded. Discrepancies between the reviewers were resolved by another researcher. 
 
Data extraction 
 
A data extraction sheet was developed and piloted. Data was extracted by two researchers 
independently, with agreement reached through discussion with a third reviewer if required. 
Outcomes were extracted according to our pre-specified framework.  
 
Quality assessment 
 
The methodological quality of included studies was assessed using the Mixed Methods Appraisal Tool 
(MMAT) – Version 2018 (19) which is designed for reviews where study designs are mixed and 
individual studies use mixed methods. The assessment was completed independently by two 
researchers and disagreements were resolved with another researcher. Studies were categorised as 
high, medium or low quality, dependent on how many MMAT-criteria were met. Quality assessment 
was used to provide context for the study findings.  
 
Data Synthesis   
 
A narrative synthesis was conducted by JG in collaboration with HA and JR. Due to the 
methodological heterogeneity of included studies, conducting a statistical meta-analysis was not 
possible. Narrative synthesis allowed for the combination of qualitative and quantitative evidence 
through the comparison of similarities and differences between studies and is a method commonly 
used to synthesise data in systematic reviews (20–23). Elements of Popay et al.’s (2006) guidance on 
the conduct of narrative synthesis were followed (24). The characteristics and key findings of studies 
were summarised and patterns across studies presented according to the population type. Next, 
factors offering explanations for relationships within and between studies were sought. 
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RESULTS 
 
Literature Search 
 
Of 4778 articles identified in the literature database search, 110 were identified at title and abstract 
stage and the full text was screened. Of these, 16 studies met the inclusion criteria. A further three 
studies were identified through the screening of the reference lists of included studies. A total of 19 
studies were included Figure 1. 
 
 
Figure 1 PRISMA Flow Diagram  
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Description of Included studies  
 
Quantitative (n=7), qualitative (n=5) and mixed methods (n=7) studies looking at pharmacy staff 
(n=11), users (n=4) and both users and staff (n=4) were included. Interviews (n=11), surveys (n=12) 
and focus groups (n=2) gave insight into users’ and staff’ experiences and attitudes. The 
characteristics of included studies are presented in Table 1. Studies reported on at least one of the 
following services: EC, Oral contraception, Contraceptive injection, Chlamydia screening, HIV 
screening and Condom distribution. 
Two qualitative and two quantitative studies included a comparator group. 
 
Quality of included studies  
 
Ten studies were of high, five of low and four of medium quality. Most studies (n=18) had clear 
research questions and appropriate data collection methods (n=16). While most qualitative studies 
were of high quality, most quantitative studies had a high risk of nonresponse bias and most mixed 
methods studies failed to adequately integrate results. The detailed quality assessment is attached as 
Supplementary File 1. 
 
Experiences and attitudes of pharmacy users and staff 
 
Pharmacy users 
Three key areas of importance to pharmacy users were identified: suitability, privacy and counselling. 
The main findings are summarised in Table 2.  
 
Suitability 
Users found pharmacies convenient, easy and quick to access and use. They liked that compared to 
other providers, no appointments needed to be organised (25–33). However, a barrier to service 
delivery experienced by some users was that trained staff were not always available to provide the 
service (32).  
 
Privacy  
All five studies evaluating ‘privacy’ did so in relation to EC or chlamydia screening. Users perceptions 
of experience conflicted within and between studies: While some were not concerned and stated that 
privacy was something they liked about pharmacies, others had privacy concerns and were worried 
about being overheard at the counter (25–31). In one study 98.9% of users of clinical services such 
as family planning services and General practices (82/83) were satisfied with the level of privacy 
provided, a significantly lower percentage (p ≤.001) of pharmacy users (44%; 22/50) were satisfied 
(25).  
 
Counselling 
With the exception of some younger individuals, pharmacy users generally had a positive counselling 
experience,  felt comfortable discussing sexual health (26–35) and found that appropriate advice was 
provided (26–28,30,31,33–35). However, in two quantitative studies, pharmacy users found 
counselling on EC less informative and satisfactory compared to users of other sexual health 
providers (25,34,35): Whereas 95% of users of clinical services (78/83) agreed that adequate advice 
on EC was provided, fewer pharmacy users (82%; 41/50) did so (25). While both clinic users (86.6%; 
100/116) and pharmacy users (81.4%; 71/87) were generally satisfied with the counselling, pharmacy 
users were slightly less satisfied than users of clinical services (34,35). 
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Table 1 Characteristics and Quality of Included Studies.  
First Author 
(Year) 
Study Component(s) of 
interest  
 
Setting Type of Intervention Comparator Relevant Pharmacy 
Population Type 
Quality  
Black (2008) Survey England Emergency Contraception Yes (Family 
Planning Clinic; 
GP) 
Pharmacy Users (n=50) Low 
Chaumont 
(2017) 
Interviews and Survey Canada Emergency Contraception No Pharmacists (Survey: n=198; 
Interviews: n=17) 
High 
Cooper (2008)  Interviews England Emergency Contraception No Pharmacists (n=23) 
 
High 
Dabrera 
(2011) 
Interviews England Chlamydia screening No Pharmacists (n=10) Medium 
Darin (2015)  Survey United 
States 
HIV screening  No Pharmacy Users (n=69) Low 
Debattista / 
Emmerton 
(2017/ 2011) 
Interviews Australia Chlamydia Screening No Pharmacists (not reported) Low 
Deeks / 
Parker 
(2014/2013) 
Interviews, Focus Groups 
and Survey 
Australia Chlamydia Screening No Pharmacy Users (Survey: 
n=945; Interviews: n=18) and 
Pharmacy Healthcare 
Assistants (Survey: 20; Focus 
group =10)  
Medium 
Downing 
(2011) 
Interviews and Survey  Australia  Emergency Contraception No Pharmacists (Survey: n=34; 
Interviews: not reported), non-
pharmacists such as pharmacy 
healthcare assistants and 
pharmacy managers (Survey: 
n=111; Interview: not reported) 
Low 
Gudka 
(2013/2009) 
Survey and Focus Groups  Australia Chlamydia Screening after 
Emergency Contraception 
No Pharmacy Users (Survey: 
n=91; Focus Group: n=5) and 
Pharmacists (Focus Group: 
n=6) 
High 
Gudka (2014) Survey Australia Emergency Contraception No Pharmacy Users (n=113) Medium 
Heller (2017) Survey and Interviews Australia Contraceptive Injection No Pharmacy Users (Survey: 
n=50) and Pharmacists 
(Interviews: not reported) 
Low 
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Hussainy 
(2011) 
Survey Australia  Emergency Contraception No Pharmacists (n=427) High 
Michie (2016) Interviews  Scotland Oral Contraception after 
Emergency Contraception 
Yes (Two types of 
pharmacy care; 
Family Planning 
Clinic) 
Pharmacy Users (n=12) and 
Pharmacists (n=10) 
High  
Ragland/ 
Ragland 
(2015) 
Survey  United 
States 
Emergency Contraception Yes (Women’s 
Clinic) 
Pharmacy Users (n=87) High 
Rodriguez 
(2018) 
Survey  United 
States 
Hormonal Contraception   Pharmacists (n=121) Medium 
Ryder (2015) Interviews  United 
States 
Condoms No Pharmacists (n=5) and 
Pharmacy Healthcare 
Assistants (n=4)  
High  
Thomas 
(2009) 
Interviews  New 
Zealand 
Chlamydia Screening after 
Emergency Contraception 
Yes (Schools; 
Health & Youth 
Centres) 
Pharmacists (n=12) High 
Whelan 
(2013) 
Survey England Emergency Contraception No Pharmacists (n=422) High  
Wong (2017) Interviews  Canada  Copper IUD consultation as 
part of Emergency 
Contraception counselling  
No Pharmacists (n=20) High  
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Table 2 Key Findings of included studies 
First Author(s) (Year) Key Findings 
Qualitative Studies  
Cooper (2008)  Some pharmacy staff were more likely give out EC to older users and were not willing to give EC to under 25s  
Dabrera (2011)  Pharmacists were supportive of pharmacy-based chlamydia screening and found service provision feasible  
 Some pharmacists were concerned about privacy outside of a consultation room  
 Pharmacists were concerned about approaching young people (under 16 years) and found it more challenging to offer STI screening to users 
attending for non-sexual health complaints 
Michie (2016)  Women used the pharmacy because they had difficulties accessing contraception elsewhere and did not want to plan an appointment ahead 
 Women felt that the information given to them about contraception was clear  
Ryder (2015)  According to pharmacists, young users were uncomfortable when requesting condoms  
 Pharmacy staff felt that dealing with groups of people together is problematic 
 Some pharmacy staff felt that young males do not use the pharmacy for condoms as the pharmacy might be seen as an intimidating 
environment due to having to talk to female staff   
Wong (2017)  Some pharmacists felt conflicted in their roles as a health care professional and a drug dispenser (pharmacists felt pressured by users to 
provide fast services rather than detailed counselling) 
 Most pharmacists were comfortable during counselling and believed that users were also comfortable 
 Some pharmacists felt that women might feel uncomfortable being counselled by male pharmacists if there is not enough privacy provided; 
Pharmacists felt that it is difficult to ask users sensitive questions  
Quantitative Studies  
Black (2008)  74% (37/50) pharmacy users and 83.1% (69/83) of users of clinical services found it easy to obtain EHC from the pharmacy (p=.163) 
 98.9% (82/83) of clinic users compared with only 44% (22/50) of pharmacy users agreed that adequate privacy had been provided (p≤.001) 
 95% (78/83) compared to 82% (41/50) of pharmacy users felt that adequate advice was provided (p=.015) 
 Only 28% (14/50) of pharmacy users compared to 90.4% (75/83) of clinic users reported that future contraception was discussed after 
accessing EC (p≤.001) 
Darin (2015)   Speed (22/52) and convenience (16/52) were the most favourable features of pharmacy users experience  
 Lack of privacy at check-in was something users (3 out of 15) did not like about the pharmacy, ‘Private’ and ‘confidential’ was something that 
users (7 out of 52) liked about the pharmacy 
Gudka (2014)  Most women (69%; 73/113) found it very easy/ easy to get to the pharmacy and felt very comfortable/comfortable discussing EC with the 
pharmacist 
 48% (54/113) of women were unconcerned/very unconcerned about privacy in the pharmacy; 29% (33/113) were unconcerned/very 
unconcerned about privacy 
Hussainy (2011)  59.7% (256/427) of pharmacists refused EC when the person presenting was not the person needing EC 
 59.5% of pharmacists preferred to counsel on EC in an area of pharmacy where confidentiality could be assured or in a separate area away 
from other pharmacy users  
 Most pharmacists counselled on EC side effects (90.2%), dosage (91.8%), efficacy in relation to time since unprotected sexual intercourse 
(88.8%); 81.9% (345/421) of pharmacists felt that it is their role to counsel on regular contraception but only 54.5% (229/420) felt that 
pharmacists should counsel on STI 
Ragland (2015)/ 
Ragland (2015) 
 The majority of both clinic users (86.6%; 100/116) and pharmacy users (81.4%; 71/87) rated ‘strongly agree’ on being satisfied with 
counselling (p=0.523) 
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 Pharmacy users (mean ± SD: 3.6±0.6) rated significantly lower (p=0.034) the statement that the counselling helped them understand EC use 
better than clinic users (mean ± SD:3.8±0.4)  
Rodriguez (2018)  87.6% of (106/121) pharmacists felt comfortable during counselling 
Whelan (2013)  The factors interfering most with pharmacists’ ability to provide EC were lack of privacy (46.1%; 195/422) and lack of staff (50.9%; 219/422) 
Mixed Methods Studies  
Chaumont (2017)  70.9% (134/189) of pharmacists were comfortable providing EC  
 For 23.3% (10/43) of pharmacists the primary reason to refuse EC was that the person presenting was not the patient   
Debattista (2017) / 
Emmerton (2011) 
 While pharmacy staff were supportive of pharmacy-based chlamydia screening, some were concerned about the workload 
Deeks (2014)/ Parker 
(2013)  
 Pharmacy users were highly satisfied with chlamydia screening service and liked the accessibility, convenience, and that there was no need 
to book an appointment or travel a long distance 
 A lack of privacy in the pharmacy was stated as a barrier by some participants 
 Some users were concerned about confidentiality and privacy (because of other people around; fear of being overheard)  
 Most pharmacy users felt that appropriate advice was provided 
 While most users felt comfortable discussing chlamydia with pharmacy staff, a few young people felt uncomfortable  
 Pharmacy assistants felt that offering sexual health services increased their job satisfaction 
 Pharmacy assistants were anxious about longer waiting times for users due to offering chlamydia screening 
 Users presenting in groups were concerning to pharmacy staff 
Downing (2011)  Pharmacy staff were aware of the importance of privacy and tried to seek a quiet consultation area away from the counter/other customers if 
no consultation room was available 
 Young age (65%; 28/43) and person presenting not being the patient needing EC (32%/ 14/43) were reasons for staff refusing EC provision 
 85% of pharmacists (109/128) and 72% of non-pharmacist staff (271/295) agreed that advice on STI and future contraception should be 
provided after EC  
Gudka (2013)/ Gudka 
(2009)  
 87% (79/91) of pharmacy users stated in a survey that they were not concerned about privacy; however, in a later survey, almost half of the 
same participants stated that they experienced a lack of privacy and in a focus group, users said that they would not feel comfortable 
discussing sexual health at the counter and preferred a private consultation area 
 Pharmacy users liked that the service was convenient to use, and no appointments needed to be booked 
 Pharmacy users felt that pharmacists handled consultations professionally and provided clear and concise information 
 Pharmacists were supportive of service provision but found that paperwork and documenting of services was time consuming  
Heller (2017)  Although most pharmacy users had a positive experience with the service delivery, some experienced difficulties (no trained staff available in 
chain pharmacies) 
 Pharmacy users found it easy to use the service and were supportive of pharmacy-based contraceptive injection 
 Pharmacists acknowledged that features of the pharmacy were appealing for users when compared to other providers and felt that the 
pharmacy was an appropriate place for contraceptive services  
Thomas (2009)  Pharmacists are concerned to offer screening to ‘older’ individuals because they might be in a long-term relationship and might feel offended 
by being offered the service 
 No pharmacists wanted to approach clients in long-term relationships, married people or people with children (pharmacists perceived ethnic 
minorities to be more likely to be married and faithful) 
 Most pharmacists believed that pharmacies are well placed to deliver chlamydia screening because of their large clientele and felt that is was 
feasible within their practice; some pharmacists were concerned that increasing the use of locums could hinder service expansion since 
locums are often untrained 
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Pharmacy Staff 
Five key areas were identified as being of importance in relation to pharmacy staff and three of these 
were the same as those important to pharmacy users: Suitability, Privacy and Counselling. The two 
further areas identified were workload and impact. The main findings are summarised in Table 2. 
 
Suitability 
Staff believed that pharmacies were well suited for the provision of sexual health services because of 
their large clientele, accessibility and convenience (32,36–39). However, some staff thought that 
pharmacies might not be ideal for condom distribution (40) as they were not frequently used by young 
men, and that young men may be hesitant in approaching female pharmacy staff to request sexual 
health services (40).  
 
Privacy  
While some pharmacy healthcare assistants generally thought that users appeared unconcerned 
about their privacy, most pharmacy staff felt that privacy was highly important to users requesting 
sexual health services (30,31,37,38,41). Thus, staff preferred to discuss sexual health in private 
consultation rooms (27,28); where none were available, they tried to counsel in private areas away 
from other users (37,38,42).  
 
Counselling 
Staff were generally comfortable counselling users and tried to be youth-friendly and non-
judgemental. Dealing with groups and asking sensitive questions were perceived as difficult 
(27,28,30,31,36,38,40,43,44). According to staff, pharmacy users with the exception of young users 
and women counselled by male staff, felt comfortable during counselling (40,44). While staff agreed 
that side effects, dosages, efficacy and future contraception should be included in EC counselling, 
they had mixed views on the provision of counselling for STIs (38,42). According to one study, fewer 
pharmacy users (28%; 14/50) than users of clinical services (90.4%; 75/83) reported receiving 
counselling for contraception after receiving EC (25). Furthermore, staff tended not to dispense EC to 
a person requesting the service on behalf of someone else (38,42,43) and made subjective 
judgments on whom to provide or offer services such as EC and chlamydia screening. For example, 
some were likely to refuse EC to young people (38,39,42). With regards to chlamydia screening, staff 
were sometimes hesitant to offer it to young users, thosepresenting for a non-sexual health services, 
and users thought to be married or in a long-term relationship (36,37). 
 
Workload  
Although staff found the provision of sexual health services feasible overall (36,37,45), they admitted 
that the counselling and paperwork added to workload (27,28,30,31,41,42). Some staff were 
concerned about long waiting times and that trained staff were not always  available to provide 
services (30,31,36,41).  
 
Impact 
Staff felt that the provision of sexual health services benefitted their profession and improved their job 
satisfaction (30–32,39,40,45). However, some staff felt conflicted in their roles as a healthcare 
professional and drug dispenser, feeling pressured to provide services quickly rather than thoroughly 
(44).  
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DISCUSSION  
 
Main Findings 
 
We aimed to examine pharmacy staff and pharmacy users’ attitudes and experiences of pharmacy-
based sexual health services. The studies we identified indicate that pharmacy-based sexual health 
services are perceived as accessible and convenient to use by both pharmacy users and pharmacy 
staff. However, lack of availability of trained staff was perceived to be a barrier for some pharmacy 
users. Furthermore, some pharmacy users and staff had privacy concerns. With the exception of 
young users and women counselled by male staff, pharmacy users and staff were generally 
comfortable with the counselling offered. However, two quantitative studies comparing the satisfaction 
on EC counselling of pharmacy users and users of other service providers showed that pharmacy 
users were less satisfied with EC counselling than users of other service providers.  
Most staff found the provision of sexual health services practically feasible, although some felt under 
time pressure, and questioned the suitability of pharmacies for condom distribution to young males. 
 
Strengths and limitations 
 
This review provides a timely overview of the literature relating to experiences of pharmacy based 
sexual health services using a systematic and robust approach. One potential limitation is that only 
studies published after 2007 and conducted in OECD member countries were included. Removing 
these restrictions might have revealed a different picture; however, they ensured that our findings can 
inform current pharmacy practice in economically developed countries. The included studies were of 
variable quality and were not always reported in line with study reporting frameworks, having missing 
data and risk of bias. This limited the conclusions that could be draw from these studies within this 
review. Mystery shopper studies were excluded from this systematic review to capture experiences 
from ‘real’ pharmacy users only. Mystery shoppers who are not in need for the service arguably 
experience the delivery of services differently from people who are in real need of the sexual health 
service. However, these studies may have added more detail to the review.  
 
Comparisons with existing literature  
 
As identified in another recent review, we found that there is insufficient evidence on pharmacy-based 
syphilis screening (46), and also on gonorrhoea screening and Hepatitis B vaccination, as no study on 
these services met our inclusion criteria. Furthermore, our review included studies which reported on 
one or more sexual health services. However, since only three studies reported on two sexual health 
services which were offered as a package, research evaluating several pharmacy services being 
delivered as part of an integrated sexual health service is required.  
 
In line with the existing literature, pharmacy-based sexual health services were perceived as 
acceptable, convenient and accessible, compared to other health providers (13–15,46). However, 
staff sometimes created barriers to access through refusing EC to young users or not offering 
chlamydia screening. Several mystery shopper studies confirm that young users may be refused 
access to EC (47–50). Young people are at particularly high risk for sexual ill-health and denying EC 
or not offering screening for STIs can have severe consequences, such as unwanted pregnancy and 
the spread of STIs. 
 
Pharmacy users in two studies perceived EC counselling as less informative or satisfactory than 
users of other providers and one of the included studies showed that few pharmacy users were 
counselled on future contraception. Several mystery shopper studies have showed that counselling 
on side effects of EC, STIs and future contraception is often not provided (47,51). Findings in this 
review suggest that time pressure and mixed views on the appropriateness of counselling in relation 
to STIs contributes to this and highlights the need for high quality training which is reviewed regularly. 
 
Pharmacy staff were concerned that men may be less comfortable when counselled by women. Also 
that women prefer to be counselled by female staff is supported by one study in which almost half of 
all women wanted to be counselled by a woman (52). Furthermore, staff believed that young males 
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were not frequently using a pharmacy to obtain condoms, because they did not want to approach 
female staff.  
This belief is in line with a study which found that young males between 16 and 17 years are less 
likely to access retail settings including pharmacies for condoms than older men between 18 and 34 
to (53).  
 
In contrast to our review and another review on STI testing (46), two previous reviews on pharmacy-
based sexual health services did not identify privacy as being of concern to patients. (14,15). 
However, we found that privacy concerns were raised in several of our included studies both in 
relation to EC and STIs, whereas this was not the case for ongoing contraception. Similiarly, one 
previous study on EC found that privacy was a concern (54) whereas a study on regular oral 
contraception did not (55). It is likely that the stigma around EC and STIs may cause users to be more 
sensitive about privacy (56). 
 
Implications for service delivery and future research 
 
Our findings suggest that to further improve pharmacy-based sexual health services, more 
transparency is required on whether appropriate trained staff are available, and if female or male 
pharmacists are present in the pharmacy. This could help users to find a pharmacy that provides 
appropriate services where they can feel comfortable attending. Improvements to pharmacist training 
would help to increase pharmacy users’ counselling satisfaction on EC. Finally, ensuring more privacy 
within a pharmacy setting might make people feel more comfortable and facilitate condom uptake in 
young men. 
 
Consequently, areas that would benefit from future research include clarifying appropriate privacy 
requirements and counselling preferences for pharmacy users. These factors may influence uptake 
and use of sexual health services. Other areas for exploration are how to increase pharmacies’ 
appeal for young users’ needs to be explored.  
As only three studies identified included pharmacy healthcare assistants, who are the first contact to 
users, future research should evaluate their experiences. There is also an evidence gap relating to 
syphilis and gonorrhoea screening and hepatitis B vaccination, and research on pharmacy-based 
provision of these services is needed. 
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Key Messages 
 This systematic review is the first to examine pharmacy staff and users’ experiences and attitudes 
of a large range of pharmacy-based sexual health services. 
 Users find pharmacies accessible and convenient to use, and staff find delivering sexual health 
services to be feasible within their practice. 
 Barriers to service delivery include lack of privacy, limited availability of trained staff, and 
subjective judgements being made on who should be offered specific services. 
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